Abstract
To find out if the failure in immunotolerance of myasthenia gravis (MG) is a possible aspect of deduction in Breg cells and to characterize B cell subsets in MG. Flow cytometry detection and enzyme-linked immunosorbent assays in peripheral blood films of 10 MG patients and 10 healthy controls (HCs) were performed after isolation of B cells. The CD19+CD5+CD1d+ Breg cells percentages were measured to complement a B cell phenotype assay and frequencies of B cell subsets. The clinical outcome measures and immunological variables of patients with MG were compared with HCs. Patients with MG had relatively lowered percentages of CD19+CD5+CD1d+ Breg cells as compared to HCs. The production of interleukin (IL)-10 and transforming growth factor (TGF)-β1 was relatively lesser in patients with MG than HCs, which were linked with more severe of MG disease status according to Myasthenia Gravis Foundation of America (MGFA) clinical classification. The reduction of cytokine production was more significant for IL-10 than TGF-β1 when compared to HCs. It has been observed that the reduced number of B cells is able to produce IL-10 in MG patients but lesser than compared to HCs. The Bregs reduction mainly was regarded by the severity of disease status, which was highly significant and also by disease duration which was statistically significant as well. The findings of the measurement of B cell phenotype assay and frequencies of B cell subsets between MGs and HCs give us new ideas to develop B cell-mediated therapies of MG such as (1) isolated B cells of MGs could be cultured with steroids, e.g., dexamethasone in vitro to see if it induces the CD19+CD5+CD1d+ Breg cells, (2) it may observe whether induced CD19+CD5+CD1d+ Bregs have higher production of IL-10 and TGF-β1, as both are linked with disease severity, and (3) after completion in vitro steps, through further research in vivo to observe whether it improves the function of MG disease status.
Highlights
In most cases of myasthenia gravis (MG), myasthenia results from free-flowing antibodies of bloodstream, which obstructs acetylcholine receptors (AChRs) at the postsynaptic myoneural junction [1]
The reduction of CD19+CD5+CD1d+ Bregs was not affected by current medications taken as all the samples were collected in the morning and right before thymectomy was done
We have found that the correlation between the reduction of CD19+CD5+CD1d+ Bregs and severity of the disease
Summary
In most cases of myasthenia gravis (MG), myasthenia results from free-flowing antibodies of bloodstream, which obstructs acetylcholine receptors (AChRs) at the postsynaptic myoneural junction [1]. In the course of immune reaction B cells actively shows positive and negative regulatory effects [7] They positively modulate immune reaction by creating antigenspecific antibody and influencing optimal T cell activation [8, 9]. They negatively modulate immune reaction by immune modulatory cytokines production, which is described in different ranges of mouse models [7, 10,11,12,13,14,15,16,17,18,19,20] are well established [7, 14, 21]. The presence and dynamics of Breg cells in patients with MG is compared with healthy controls (HCs)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
